Arbutus Biopharma (ABUS) Other Gross PP&E Adjustments: 2009-2024
Historic Other Gross PP&E Adjustments for Arbutus Biopharma (ABUS) over the last 15 years, with Dec 2024 value amounting to $15.3 million.
- Arbutus Biopharma's Other Gross PP&E Adjustments rose 0.65% to $15.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was $11.5 million, marking a year-over-year increase of 10.98%. This contributed to the annual value of $15.3 million for FY2024, which is 0.65% up from last year.
- Latest data reveals that Arbutus Biopharma reported Other Gross PP&E Adjustments of $15.3 million as of Q4 2024, which was up 1,433.65% from -$1.1 million recorded in Q3 2024.
- Arbutus Biopharma's 5-year Other Gross PP&E Adjustments high stood at $15.3 million for Q4 2024, and its period low was -$2.7 million during Q1 2020.
- In the last 3 years, Arbutus Biopharma's Other Gross PP&E Adjustments had a median value of -$1.4 million in 2023 and averaged $2.5 million.
- Data for Arbutus Biopharma's Other Gross PP&E Adjustments shows a peak YoY rose of 23.83% (in 2024) over the last 5 years.
- Quarterly analysis of 5 years shows Arbutus Biopharma's Other Gross PP&E Adjustments stood at $12.1 million in 2020, then rose by 9.24% to $13.3 million in 2021, then increased by 6.50% to $14.1 million in 2022, then increased by 7.30% to $15.2 million in 2023, then rose by 0.65% to $15.3 million in 2024.
- Its Other Gross PP&E Adjustments stands at $15.3 million for Q4 2024, versus -$1.1 million for Q3 2024 and -$1.2 million for Q2 2024.